IFNG and neoplasm: Nanoparticle-mediated combination therapies can benignly modulate the tumor microenvironment through the activation of tumor-infiltrating T lymphocytes and natural killer cells, as well as the promotion of IFN-γ and IL-12 cytokine secretion.